Shumei Man Transmigration Across an in Vitro Blood-Brain Barrier CXCL 12-Induced Monocyte-Endothelial Interactions Promote Lymphocyte

brain. inflamed tissues and should spur progress for identifying the best targets for blocking harmful inflammation in the opens up new vistas for understanding how white blood cells and vessel wall endothelial cells ''talk'' to each other in empowered these cells to assist other white blood cells such as T and B cells to cross the BBB. This surprising result type, monocytes, showed altered CXCR4 expression. CXCR4 appeared to deliver signals to monocytes, which they added the triggering molecule for CXCR4 to their in vitro system, unexpectedly, they found that only one cell BBB. They studied a chemokine receptor termed CXCR4, which is expressed on almost all white blood cells. When establish how chemokine receptor expression by white blood cells would alter as the cells transmigrated across the transmigrated across the BBB-like endothelial layer into the lower chamber of the device. The researchers wanted to in brain capillaries. Some white blood cells flowed across the layer and out of the device, whereas others chamber. Then, they allowed human white blood cells to flow across the layer at a flow rate approximating that found First, the authors coaxed a special type of human endothelial cell to form a BBB-like layer in a dual perfusion transmigration of white blood cells across a human BBB-like endothelial cell layer. barrier (BBB). They use this elegant model to study how chemokine receptors influence and are influenced by the colleagues have devised an in vitro model of a specialized vessel wall of the human brain termed the blood-brain tissue, and they change as white blood cells transmigrate across different vessel walls. In a new study, Man and inflammation. Chemokine receptors are molecules on white blood cell surfaces that receive signals to guide cells into white blood cells transmigrate), it is important to identify those molecules that are most directly involved in harmful blood vessels and into tissues. Because there are 100 or so such molecules (used selectively when specific types of (chemokine receptors and their chemokine ligands; adhesion molecules) of white blood cell transmigration out of the apparently healthy uninfected tissues and cause injury. Recent research has identified the molecular regulators human diseases such as rheumatoid arthritis, multiple sclerosis, psoriasis, or type 1 diabetes, white blood cells invade migrate into inflamed tissues to defend the host against microbes or to repair damaged tissue. However, in many White blood cells traffic ceaselessly throughout the body, using blood vessels as their conduits. They also Going with the Flow

[1]  R. Ransohoff,et al.  CXCR3-Dependent Plasma Blast Migration to the Central Nervous System during Viral Encephalomyelitis , 2011, Journal of Virology.

[2]  David W. Holman,et al.  CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity , 2011, The Journal of experimental medicine.

[3]  J. Rubenstein,et al.  CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration , 2011, Neuron.

[4]  T. Schall,et al.  CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes , 2010, The Journal of Immunology.

[5]  A. Mantovani,et al.  Chemokine receptors intracellular trafficking. , 2010, Pharmacology & therapeutics.

[6]  M. Weinand,et al.  Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier , 2010, Nature Protocols.

[7]  G. Luker,et al.  Constitutive and Chemokine-dependent Internalization and Recycling of CXCR7 in Breast Cancer Cells to Degrade Chemokine Ligands , 2010, Oncogene.

[8]  Y. Xiong,et al.  Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family , 2010, Proteins.

[9]  R. Ransohoff,et al.  Monocytes Regulate T Cell Migration through the Glia Limitans during Acute Viral Encephalitis , 2010, Journal of Virology.

[10]  K. Dorovini‐Zis,et al.  Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide , 2010, Journal of Neuroinflammation.

[11]  H. Wekerle,et al.  Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.

[12]  R. Ransohoff Immunology: In the beginning , 2009, Nature.

[13]  G. Luker,et al.  Imaging ligand-dependent activation of CXCR7. , 2009, Neoplasia.

[14]  R. Klein,et al.  IL-1R Signaling within the Central Nervous System Regulates CXCL12 Expression at the Blood-Brain Barrier and Disease Severity during Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.

[15]  R. Ransohoff,et al.  α4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions , 2009, Journal of Neuroimmunology.

[16]  R. Ransohoff,et al.  Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function , 2009, Neurology.

[17]  M. Diamond,et al.  CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis , 2008, Proceedings of the National Academy of Sciences.

[18]  Hosung Jung,et al.  The Chemokine Stromal Cell-Derived Factor-1 Regulates GABAergic Inputs to Neural Progenitors in the Postnatal Dentate Gyrus , 2008, The Journal of Neuroscience.

[19]  R. Schmidt,et al.  Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. , 2008, The American journal of pathology.

[20]  R. Ransohoff,et al.  Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration , 2008, Clinical & developmental immunology.

[21]  R. Ransohoff,et al.  Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology , 2008, Progress in Neurobiology.

[22]  I. Campbell,et al.  CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System1 , 2007, The Journal of Immunology.

[23]  R. Ransohoff,et al.  Natalizumab for multiple sclerosis. , 2007, The New England journal of medicine.

[24]  Luca Cucullo,et al.  Development of a Humanized In Vitro Blood–Brain Barrier Model to Screen for Brain Penetration of Antiepileptic Drugs , 2007, Epilepsia.

[25]  S. Milano,et al.  Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.

[26]  R. Alon,et al.  Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm. , 2007, Blood.

[27]  R. Klein,et al.  CXCL12 Limits Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[28]  R. Rudick,et al.  Chemokine Receptors as Biomarkers in Multiple Sclerosis , 2006, Disease markers.

[29]  Kevin Wei,et al.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.

[30]  R. Ransohoff,et al.  CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. , 2006, Cellular immunology.

[31]  B. Engelhardt Molecular mechanisms involved in T cell migration across the blood–brain barrier , 2006, Journal of Neural Transmission.

[32]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[33]  B. Engelhardt,et al.  The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. , 2005, Trends in immunology.

[34]  Cheng Dong,et al.  Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. , 2005, American journal of physiology. Cell physiology.

[35]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[36]  R. Ransohoff,et al.  CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer , 2004, Journal of Neuroimmunology.

[37]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[38]  R. Ransohoff,et al.  Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.

[39]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Culmsee,et al.  A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia , 2002, The Journal of Neuroscience.

[41]  S. Cuvelier,et al.  Shear-dependent Eosinophil Transmigration on Interleukin 4–stimulated Endothelial Cells , 2001, The Journal of experimental medicine.

[42]  R. Ransohoff,et al.  Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. , 2001, Archives of neurology.

[43]  R. Alon,et al.  Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines , 2001, Nature Immunology.

[44]  R. Alon,et al.  Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow , 2001, Journal of leukocyte biology.

[45]  H. Weiner,et al.  Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.

[46]  W. Kuziel,et al.  Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.

[47]  R. Hubbard,et al.  Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. , 1999, Biochemistry.

[48]  M. Delepierre,et al.  Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine* , 1999, The Journal of Biological Chemistry.

[49]  T. Springer,et al.  The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. , 1999, Immunity.

[50]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[51]  F. Gilles,et al.  Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.

[52]  R. Hershkoviz,et al.  Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. , 1994, Journal of immunology.

[53]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[54]  G. Gray,et al.  Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. , 1991, Cancer research.

[55]  Matthias Mack,et al.  Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. , 2006, Brain : a journal of neurology.

[56]  R. Ransohoff,et al.  The expression and function of chemokines involved in CNS inflammation. , 2006, Trends in pharmacological sciences.

[57]  C. Yiannoutsos,et al.  SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. , 2003, Journal of neuropathology and experimental neurology.

[58]  R. Klein,et al.  SDF-1 α induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells , 2001 .

[59]  E. Kaldjian,et al.  Orchestrated information transfer underlying leukocyte endothelial interactions. , 1996, Annual review of immunology.

[60]  A. Hudetz,et al.  Heterogeneous autoregulation of cerebrocortical capillary flow: evidence for functional thoroughfare channels? , 1996, Microvascular research.

[61]  D. Adams,et al.  T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. , 1993, Nature.

[62]  Steffen Jung,et al.  The FASEB Journal • Research Communication The neuronal chemokine CX3CL1/fractalkine , 2022 .